miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer.

Yue YuWen YinZhi-Hao YuYan-Jun ZhouJiang-Rui ChiJie GeXu-Chen Cao

Published in: Journal of experimental & clinical cancer research : CR (2019)

Our data uncover the ZEB1/ERα-miR-190-SOX9 axis and suggest a mechanism by which the Wnt/β-catenin signaling pathway is involved in breast cancer anti-estrogen therapy.

Keyphrases

long non coding rna
cell proliferation
poor prognosis
stem cells
transcription factor
estrogen receptor
epithelial mesenchymal transition
cell therapy
binding protein
signaling pathway